- Home
- CMPS vs SIFY Comparison
CMPS vs SIFY Comparison
Compare CMPS & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- SIFY
- Stock Information
- Founded
- CMPS 2020
- SIFY 1995
- Country
- CMPS United Kingdom
- SIFY India
- Employees
- CMPS N/A
- SIFY N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- SIFY Computer Software: Programming Data Processing
- Sector
- CMPS Health Care
- SIFY Technology
- Exchange
- CMPS Nasdaq
- SIFY Nasdaq
- Market Cap
- CMPS 280.2M
- SIFY 218.1M
- IPO Year
- CMPS 2020
- SIFY 1999
- Fundamental
- Price
- CMPS $4.16
- SIFY $3.17
- Analyst Decision
- CMPS Strong Buy
- SIFY
- Analyst Count
- CMPS 6
- SIFY 0
- Target Price
- CMPS $33.60
- SIFY N/A
- AVG Volume (30 Days)
- CMPS 666.3K
- SIFY 68.3K
- Earning Date
- CMPS 10-31-2024
- SIFY 01-16-2025
- Dividend Yield
- CMPS N/A
- SIFY N/A
- EPS Growth
- CMPS N/A
- SIFY N/A
- EPS
- CMPS N/A
- SIFY N/A
- Revenue
- CMPS N/A
- SIFY $443,027,157.00
- Revenue This Year
- CMPS N/A
- SIFY N/A
- Revenue Next Year
- CMPS N/A
- SIFY $12.52
- P/E Ratio
- CMPS N/A
- SIFY $56.05
- Revenue Growth
- CMPS N/A
- SIFY 5.85
- 52 Week Low
- CMPS $3.86
- SIFY $1.80
- 52 Week High
- CMPS $12.75
- SIFY $11.64
- Technical
- Relative Strength Index (RSI)
- CMPS 35.91
- SIFY 46.52
- Support Level
- CMPS $3.86
- SIFY $2.80
- Resistance Level
- CMPS $4.20
- SIFY $3.05
- Average True Range (ATR)
- CMPS 0.28
- SIFY 0.19
- MACD
- CMPS 0.00
- SIFY -0.04
- Stochastic Oscillator
- CMPS 8.06
- SIFY 33.33
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.